Determination of moxifloxacin in dried blood spots using LC–MS/MS and the impact of the hematocrit and blood volume

The Effect of Hematocrit on Assay Bias When Using DBS Samples for The Quantitative Bioanalysis of Drugs

Philip Denniff, Neil Spooner · Bioanalysis · 2010 · 317 citations

Selection of a Moxifloxacin Dose That Suppresses Drug Resistance in<i>Mycobacterium tuberculosis,</i>by Use of an In Vitro Pharmacodynamic Infection Model and Mathematical Modeling

Tawanda Gumbo, Arnold Louie, Mark R. Deziel et al. · The Journal of Infectious Diseases · 2004 · 315 citations

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

Marcus Barreto Conde, Anne Efron, Carla Loredo et al. · The Lancet · 2009 · 292 citations · Full text

Pulmonary Tuberculosis, Moxibustion, Phase Ii Trial +9

A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

Roxana Rustomjee, Christian Lienhardt, Thomas P. Kanyok et al. · PubMed · 2008 · 284 citations

Ion suppression : A major concern in mass spectrometry

Lori Lee Jessome, Dietrich A. Volmer · National Research Council Canada (Government of Canada) · 2006 · 183 citations

Ion Mobility Spectrometry, Gas Chromatography, Chromatography-mass Spectrometry +17